Celebrating McGill-Tel Aviv University (TAU) Collaboration in Brain Protection: From Autism to Neuropsychiatric and Neurodegenerative Diseases Supported by the Eldee Foundation and Bloomfield Family... Read more
Prof. Joseph D. Buxbaum, PhD Director of the Seaver Autism Center, Icahn School of Medicine at Mount Sinai. His research interest is focused on human psychiatric and neurological diseases using...
The vast majority of children with an ADNP mutation grow a nearly full set of baby teeth, including molars, before their first birthday... Read more
On World Autism Awareness Day, we highlight the importance of addressing the causes and improving the treatments for autism spectrum disorders (ASDs)... Read more
Coronis NeuroSciences is a specialty pharma company focused on the development of innovative therapies in the fields of Neurocognitive and Neurodegenerative disorders. The company owns a pipeline of several clinical and pre-clinical stage molecules and strives to build value through the clinical development of cutting-edge propriety formulated drugs.
